[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 94 of about 94
91. Köhler G: [Uterine sarcoma treatment]. Pathologe; 2009 Jul;30(4):304-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There are many common features between uterine sarcomas - leiomyosarcoma, endometrial stromal sarcoma, undifferentiated endometrial sarcoma and adenosarcoma -with regards to course, therapy and follow-up, such as post-menopausal bleeding or additional premenopausal bleeding, as well as rapid growth.
  • In the case of disease spread in uterine sarcomas and malignant mixed tumors, good supportive therapy is a possible therapy option instead of chemo- or radiotherapy.

  • Genetic Alliance. consumer health - Uterine sarcoma.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Gynecol Oncol. 1994 Jan;52(1):74-9 [8307505.001]
  • [Cites] Gynecol Oncol. 2003 Jun;89(3):460-9 [12798712.001]
  • [Cites] Cancer. 2008 Feb 15;112(4):820-30 [18189292.001]
  • [Cites] Gynecol Oncol. 2001 Oct;83(1):89-94 [11585418.001]
  • [Cites] Gynecol Oncol. 2004 Feb;92(2):644-7 [14766260.001]
  • [Cites] Gynecol Oncol. 1993 Jul;50(1):105-9 [8349151.001]
  • [Cites] J Clin Oncol. 1985 Sep;3(9):1240-5 [3897471.001]
  • [Cites] Int J Gynecol Cancer. 2008 Sep-Oct;18(5):1084-9 [18179547.001]
  • [Cites] Curr Opin Oncol. 2007 Jul;19(4):347-52 [17545798.001]
  • [Cites] Gynecol Oncol. 2009 Mar;112(3):563-7 [19135708.001]
  • [Cites] Oncol Rep. 1998 Jul-Aug;5(4):939-44 [9625851.001]
  • [Cites] Crit Rev Oncol Hematol. 2008 Feb;65(2):129-42 [17706430.001]
  • [Cites] Gynecol Oncol. 1996 Aug;62(2):226-9 [8751554.001]
  • [Cites] Ann Surg. 1999 May;229(5):602-10; discussion 610-2 [10235518.001]
  • [Cites] Ann Surg. 2000 Apr;231(4):500-5 [10749609.001]
  • [Cites] Gynecol Oncol. 2008 Jul;110(1):43-8 [18445505.001]
  • [Cites] Int J Gynecol Cancer. 2007 Sep-Oct;17(5):957-63 [17359294.001]
  • [Cites] Gynecol Oncol. 2008 Oct;111(1):74-81 [18657852.001]
  • [Cites] Cancer. 1993 Feb 15;71(4 Suppl):1702-9 [8381710.001]
  • [Cites] Cancer. 1983 Aug 15;52(4):626-32 [6344983.001]
  • [Cites] Int J Gynecol Pathol. 1992;11(2):75-88 [1316323.001]
  • [Cites] Gynecol Oncol. 1990 Jan;36(1):113-8 [2295442.001]
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 2009 May;144(1):80-4 [19269732.001]
  • [Cites] Eur J Gynaecol Oncol. 2006;27(2):150-2 [16620058.001]
  • [Cites] Gynecol Obstet Fertil. 2003 Feb;31(2):147-50 [12718990.001]
  • [Cites] Gynecol Oncol. 2007 Jul;106(1):82-8 [17434579.001]
  • [Cites] Gynecol Oncol. 2003 Jul;90(1):170-6 [12821359.001]
  • [Cites] J Clin Oncol. 2007 Jul 20;25(21):3144-50 [17634494.001]
  • [Cites] Am J Obstet Gynecol. 1992 Feb;166(2):556-9 [1536229.001]
  • [Cites] Obstet Gynecol. 1996 May;87(5 Pt 1):747-50 [8677079.001]
  • [Cites] Curr Opin Oncol. 2007 Sep;19(5):492-6 [17762577.001]
  • [Cites] Br J Cancer. 1995 Aug;72(2):469-75 [7640234.001]
  • [Cites] Gynecol Oncol. 2008 Jun;109(3):329-34 [18534250.001]
  • [Cites] Br J Cancer. 2007 Nov 5;97(9):1194-9 [17895898.001]
  • [Cites] Obstet Gynecol. 2008 Jul;112(1):64-70 [18591309.001]
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 1998 Feb;76(2):237-40 [9481582.001]
  • [Cites] Mod Pathol. 2004 Jan;17(1):104-8 [14631363.001]
  • [Cites] Gynecol Oncol. 1996 Jul;62(1):25-32 [8690287.001]
  • [Cites] Gynecol Oncol. 2005 Oct;99(1):36-42 [15992918.001]
  • [Cites] Int J Gynecol Cancer. 2005 Jan-Feb;15(1):132-9 [15670308.001]
  • [Cites] Hum Pathol. 1990 Apr;21(4):363-81 [2156771.001]
  • [Cites] Eur J Cancer. 2008 Apr;44(6):808-18 [18378136.001]
  • [Cites] Eur J Gynaecol Oncol. 2008;29(2):129-34 [18459545.001]
  • [Cites] Gynecol Oncol. 2006 Jun;101(3):464-9 [16368128.001]
  • [Cites] Int J Gynecol Cancer. 2006 May-Jun;16(3):1358-63 [16803530.001]
  • [Cites] Gynecol Oncol. 1996 Aug;62(2):254-9 [8751558.001]
  • [Cites] Clin Oncol (R Coll Radiol). 2008 Aug;20(6):470-8 [18572394.001]
  • [Cites] Oncology. 2006;71(5-6):333-40 [17690557.001]
  • [Cites] Gynecol Oncol. 2004 Feb;92(2):648-52 [14766261.001]
  • [Cites] Am J Surg Pathol. 2008 Jul;32(7):1013-21 [18469708.001]
  • [Cites] Gynecol Oncol. 2007 Apr;105(1):256-60 [17292949.001]
  • [Cites] Obstet Gynecol. 2008 Nov;112(5):1102-8 [18978112.001]
  • [Cites] Obstet Gynecol. 2005 Dec;106(6):1304-8 [16319256.001]
  • [Cites] Br J Cancer. 2008 Oct 21;99(8):1210-5 [18813312.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Dec 1;57(5):1366-73 [14630275.001]
  • [Cites] Ann Surg Oncol. 2005 Jun;12(6):459-66 [15886903.001]
  • [Cites] Eur J Cancer. 1997 May;33(6):907-11 [9291814.001]
  • [Cites] Gynecol Oncol. 2005 Oct;99(1):243-5 [16054205.001]
  • [Cites] Br J Cancer. 2000 Mar;82(5):1030-4 [10737385.001]
  • [Cites] Int J Gynecol Cancer. 2007 May-Jun;17(3):724-8 [17300682.001]
  • [Cites] Am J Surg Pathol. 2008 Aug;32(8):1228-38 [18580489.001]
  • [Cites] Gynecol Oncol. 2004 Apr;93(1):204-8 [15047237.001]
  • [Cites] Am J Obstet Gynecol. 2008 Nov;199(5):536.e1-8 [18511017.001]
  • [Cites] Gynecol Oncol. 2005 Feb;96(2):402-6 [15661228.001]
  • [Cites] J Clin Oncol. 2009 Apr 20;27(12):2066-72 [19255317.001]
  • [Cites] Ann Surg. 2001 Oct;234(4):540-7; discussion 547-8 [11573047.001]
  • [Cites] Gynecol Oncol. 2007 Dec;107(3):518-25 [17910981.001]
  • [Cites] Gynecol Oncol. 2007 Jan;104(1):260-3 [17083970.001]
  • [Cites] Gynecol Oncol. 1992 May;45(2):202-5 [1592288.001]
  • [Cites] Gynecol Oncol. 2007 Jun;105(3):630-4 [17320937.001]
  • [Cites] Int J Gynecol Pathol. 1999 Jan;18(1):20-8 [9891238.001]
  • [Cites] J Obstet Gynaecol Can. 2008 Jun;30(6):500-4 [18611301.001]
  • [Cites] Histopathology. 2009 Feb;54(3):355-64 [19236512.001]
  • [Cites] Int J Gynecol Cancer. 2009 Feb;19(2):253-6 [19396004.001]
  • [Cites] Int J Gynecol Cancer. 2009 Feb;19(2):257-60 [19396005.001]
  • [Cites] Int J Gynecol Cancer. 2004 Nov-Dec;14(6):1118-21 [15571618.001]
  • [Cites] Gynecol Oncol. 2002 Dec;87(3):287-94 [12468327.001]
  • [Cites] Gynecol Oncol. 2003 Oct;91(1):209-12 [14529683.001]
  • [Cites] Cancer. 1985 Apr 15;55(8):1648-53 [3884128.001]
  • [Cites] Gynecol Oncol. 2008 Feb;108(2):306-11 [18061249.001]
  • [Cites] Am J Surg Pathol. 2009 Feb;33(2):278-88 [18941402.001]
  • [Cites] J Clin Oncol. 2002 Jun 15;20(12):2824-31 [12065559.001]
  • (PMID = 19517111.001).
  • [ISSN] 1432-1963
  • [Journal-full-title] Der Pathologe
  • [ISO-abbreviation] Pathologe
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


92. Tjalma WA, Michener CM: Mullerian adenosarcoma of the uterus associated with long-term oral contraceptive use. Eur J Obstet Gynecol Reprod Biol; 2005 Apr 1;119(2):253-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mullerian adenosarcoma of the uterus associated with long-term oral contraceptive use.
  • [MeSH-major] Adenosarcoma / chemically induced. Contraceptives, Oral / adverse effects. Mullerian Ducts. Uterine Neoplasms / chemically induced

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15808391.001).
  • [ISSN] 0301-2115
  • [Journal-full-title] European journal of obstetrics, gynecology, and reproductive biology
  • [ISO-abbreviation] Eur. J. Obstet. Gynecol. Reprod. Biol.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Contraceptives, Oral
  •  go-up   go-down


93. Chung YW, Bae HS, Han SI, Song JY, Kim IS, Kang JS: Endometrial mullerian adenosarcoma after toremifene treatment in breast cancer patients: a case report. J Gynecol Oncol; 2010 Dec 30;21(4):269-72
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endometrial mullerian adenosarcoma after toremifene treatment in breast cancer patients: a case report.
  • We report a case of an adenosarcoma, which is a very rare type of uterine malignancy, after toremifene treatment for 5 years in a breast cancer patient.
  • After 1 year of toremifene use, the patient had a benign Mullerian adenofibroma.
  • After an additional 4 years of toremifene treatment, the endometrial polypoid lesion was transformed into a Mullerian adenosarcoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Rev Hosp Clin Fac Med Sao Paulo. 2000 Jan-Feb;55(1):17-20 [10881074.001]
  • [Cites] J Clin Oncol. 2000 Oct 15;18(20):3487-94 [11032589.001]
  • [Cites] Arch Gynecol Obstet. 2000 Sep;264(2):105-7 [11045336.001]
  • [Cites] Br J Cancer. 2001 Apr 6;84(7):897-902 [11286468.001]
  • [Cites] AJR Am J Roentgenol. 2003 Dec;181(6):1673-5 [14627594.001]
  • [Cites] Breast. 2006 Apr;15(2):142-57 [16289904.001]
  • [Cites] Int J Gynecol Cancer. 2006 Mar-Apr;16(2):861-5 [16681774.001]
  • [Cites] Eur J Cancer. 2009 Mar;45(4):561-71 [19062268.001]
  • [Cites] Breast Cancer Res Treat. 1993;25(1):57-63 [8518408.001]
  • [Cites] Ann Oncol. 2004 Dec;15(12):1749-59 [15550579.001]
  • (PMID = 21278890.001).
  • [ISSN] 2005-0399
  • [Journal-full-title] Journal of gynecologic oncology
  • [ISO-abbreviation] J Gynecol Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC3026307
  • [Keywords] NOTNLM ; Breast cancer / Mullerian adenofibroma / Mullerian adenosarcoma / Tamoxifen / Toremifene
  •  go-up   go-down


9
Advertisement
4. Zámecník M, Sosna B, Chlumská A: Gastrointestinal stromal tumor (GIST) with glandular component. A report of an unusual tumor resembling adenosarcoma. Cesk Patol; 2005 Oct;41(4):150-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Gastrointestinal stromal tumor (GIST) with glandular component. A report of an unusual tumor resembling adenosarcoma.
  • Histologically, the lesion showed a biphasic adenosarcoma-like structure.
  • [MeSH-major] Adenosarcoma / pathology. Gastrointestinal Stromal Tumors / pathology. Stomach Neoplasms / pathology

  • Genetic Alliance. consumer health - Gastrointestinal Stromal Tumors.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16382991.001).
  • [ISSN] 1210-7875
  • [Journal-full-title] Československá patologie
  • [ISO-abbreviation] Cesk Patol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Czech Republic
  •  go-up   go-down






Advertisement